# Aspirin as a Pre-Treatment for Exercise in Multiple Sclerosis

> **NCT03051646** · EARLY_PHASE1 · COMPLETED · sponsor: **Columbia University** · enrollment: 12 (actual)

## Conditions studied

- Fatigue
- Overheating

## Interventions

- **DRUG:** Acetylsalicylic acid at 1st visit, then Placebo at 2nd visit
- **DRUG:** Placebo at 1st visit, then Acetylsalicylic acid at 2nd visit

## Key facts

- **NCT ID:** NCT03051646
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-13
- **Primary completion:** 2017-05-10
- **Final completion:** 2017-05-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2018-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03051646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03051646, "Aspirin as a Pre-Treatment for Exercise in Multiple Sclerosis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03051646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*